Nu Skin Enterprises, Inc. (NUS): Shareholders' Equity

Annual figures by period end, from SEC filings.

$805.24M
As of 2025-12-31
$542.74M
As of 2026-06-30
-3.5%
3-year compound annual growth
-2.1%
5-year compound annual growth
-0.2%
10-year compound annual growth
$942.44M2008-12-31: $316.18M2009-12-31: $375.69M2010-12-31: $471.25M2011-12-31: $574.24M2012-12-31: $590.61M2013-12-31: $858.62M2014-12-31: $942.44M2015-12-31: $825.62M2016-12-31: $664.07M2017-12-31: $704.60M2018-12-31: $781.87M2019-12-31: $875.29M2020-12-31: $894.27M2021-12-31: $912.77M2022-12-31: $897.30M2023-12-31: $821.97M2024-12-31: $651.46M2025-12-31: $805.24M$805.24M
2008-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$805.24M+23.6%2026-02-13, Balance as of period end
2024-12-31$651.46M-20.7%2026-02-13, Balance as of period end
2023-12-31$821.97M-8.4%2025-02-14, Balance as of period end
2022-12-31$897.30M-1.7%2024-02-15, Balance as of period end
2021-12-31$912.77M+2.1%2023-02-16, Balance as of period end
2020-12-31$894.27M+2.2%2022-02-16, Balance as of period end
2019-12-31$875.29M+11.9%2021-02-11, Balance as of period end
2018-12-31$781.87M+11.0%2020-02-13, Balance as of period end
2017-12-31$704.60M+6.1%2019-02-14, Balance as of period end
2016-12-31$664.07M-19.6%2018-02-16, Balance as of period end
2015-12-31$825.62M-12.4%2017-02-27, Balance as of period end
2014-12-31$942.44M+9.8%2016-02-18, Balance as of period end
2013-12-31$858.62M+45.4%2015-03-02, Balance as of period end
2012-12-31$590.61M+2.9%2014-03-18, Balance as of period end
2011-12-31$574.24M+21.9%2013-02-27, Balance as of period end
2010-12-31$471.25M+25.4%2012-02-28, Balance as of period end
2009-12-31$375.69M+18.8%2011-02-23, Balance as of period end
2008-12-31$316.18Mn/a2011-02-23, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Nu Skin Enterprises, Inc. (NUS)2025-12-31$805.24M+23.6%
Herbalife Ltd. (HLF)2025-12-31-$515.10Mn/m
Cosmos Health Inc. (COSM)2025-12-31$18.42M-24.9%
DataMeds AI, Inc. (MEDS)2025-12-31-$12.45Mn/m
Cardinal Health Inc (CAH)2026-06-30-$2.88Bn/m
Cencora, Inc. (COR)2025-09-30$1.51B+133.5%
McKesson Corp (MCK)2026-03-31-$1.78Bn/m
Stemtech Corp (STEK)2025-12-31-$6.96Mn/m
HWH International Inc. (ESYN)2025-12-31$2.62M-5.3%

Compare NUS, HLF, COSM, MEDS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗